3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
8
Solid Tumor
1
Peripheral Nervous System Diseases
1
Neoplasm, Residual
1
Hypoxia
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Estrogen Receptor Positive Breast Cancer
1
Breast Neoplasms, Male
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
palbociclib
2
Trastuzumab
2
Capecitabine
2
trastuzumab deruxtecan
1
tetrathiomolybdate
1
sacituzumab govitecan
1
pembrolizumab
1
niraparib
1
inavolisib
1
giredestrant
1
eribulin
1
avelumab
1
atezolizumab
1
abemaciclib
1
Zymosan
1
Radiotherapy
1
Letrozole
1
Immunotherapy
1
Hydroxychloroquine
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Hydroxychloroquine
×
Breast
×
Clear all
NCT04841148
2026-04-09
PALAVY
Abramson Cancer Center at Penn Medicine
Phase 2
Recruiting
96 enrolled